Summary
The U.S. Food and Drug Administration (FDA) has approved a version of leucovorin, a drug also known as folinic acid, which is made by GlaxoSmithKline. The drug is approved for treating symptoms of autism, based on data from 40 patients with cerebral folate deficiency. President Donald Trump made an announcement about this approval, despite the ongoing debate about the drug’s effectiveness for autism treatment.
Key Facts
- The FDA approved leucovorin, a form of vitamin B9, to help with some autism symptoms.
- Leucovorin has been used to counteract side effects of certain cancer drugs.
- The current approval is based on data from 40 patients with a disorder that can cause autism-like symptoms.
- President Trump spoke publicly about the approval and discussed autism, without providing new evidence.
- Some studies suggest leucovorin might improve symptoms in children with autism, but evidence is limited.
- Experts call for larger studies to determine leucovorin's effectiveness for treating autism.
- Leucovorin can be taken by mouth or given through an IV.
- Folate is essential for healthy cell growth and preventing certain birth defects.
